Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / Diabetes Risk Assessment: A New Approach
Endocrinology Genetics and epigenetics Liquid biopsy Technology and innovation Molecular Pathology Research and Innovations

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

By Helen Bristow 03/09/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
  • Top Thought Leaders

Share

Top Institutions in Endocrinology and Diabetes Research

Leading institutions in diabetes research combine clinical expertise in endocrinology with advanced molecular biology and bioinformatics capabilities to develop and validate novel biomarkers, including epigenetic markers, for early diabetes risk stratification and prevention strategies.

  • #1

    German Center for Diabetes Research (DZD)

    München, Bavaria

    DZD leads in integrating molecular epigenetics with clinical diabetes research, exemplified by pioneering work on DNA methylation markers for diabetes risk assessment, supported by strong collaborations across German academic and clinical centers.

    Key Differentiators

    • Diabetes Research
    • Epigenetics
    • Endocrinology
  • #2

    Joslin Diabetes Center, Harvard Medical School

    Boston, Massachusetts

    Joslin is a world-renowned diabetes research and clinical care institution with extensive expertise in biomarker discovery, genetics, and epigenetics of diabetes, leveraging large patient cohorts and advanced molecular technologies.

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Genomics
  • #2

    Joslin Diabetes Center, Harvard Medical School

    Boston, Massachusetts

    Joslin is a world-renowned diabetes research and clinical care institution with extensive expertise in biomarker discovery, genetics, and epigenetics of diabetes, leveraging large patient cohorts and advanced molecular technologies.

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Genomics
  • #3

    University of California, San Francisco (UCSF) Diabetes Center

    San Francisco, California

    UCSF combines clinical diabetes care with cutting-edge research in epigenetics and metabolic diseases, focusing on novel biomarkers and personalized medicine approaches to diabetes risk and management.

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Epigenetics
  • #4

    Imperial College London, Diabetes Research Group

    London, England

    Imperial College has a strong translational research program in diabetes, including epigenetic and genomic studies aimed at improving early detection and prevention of Type 2 diabetes.

    Key Differentiators

    • Diabetes Research
    • Endocrinology
    • Epigenetics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.